LandMe

Medical Project Assistant

Zealand Pharma U.S., Inc. · Cambridge, Massachusetts

OnsitePart-timeDirect from the employer

Posted Oct 7, 2026 · Verified open Oct 9, 2026

Apply on the employer's siteFind more jobs like this on LandMe

About the job

Does it excite you to work with Medical Affairs leadership, and do you have experience providing high-level administrative support in a fast-paced, cross-functional environment? If this sounds like you, and you are ready to take on a broad area of responsibilities, then you could be our new colleague.

Your new position (Part Time Role @ 20-25 hrs/week)

Your profile

Your new team
You will report to the VP of US Medical Affairs and provide support to the VP of US Medical Affairs, the VP of Global Medical Affairs, and the SVP Senior Medical Advisor. You will be a key enabler of the Medical Affairs leadership team's day-to-day effectiveness, working closely with leaders and their teams to keep operations running smoothly.

Let's bond and be bold
We have a unique culture, characterized by excellent teamwork and strong engagement across the organization. And we want you to help us strengthen this culture.
Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other. We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Join us and let's bond and be bold.
Interested in bonding with us? While a cover letter is not required, please include a few sentences in your CV explaining your motivation for applying.
We are committed to an inclusive recruitment process and welcome applications from all job applicants.

About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary data platform that leverages advanced data-driven and AI/ML approaches, Zealand Pharma aims to lead a new era in obesity and metabolic health. To date, more than ten Zealand Pharma-invented drug candidates have entered clinical development, of which two products have reached the market and three candidates are in late-stage development. The Company has collaborations with global pharmaceutical and biotechnology partners for research, development, and commercialization. Founded in 1998, Zealand Pharma is headquartered in Copenhagen, Denmark, with a U.S. presence in Boston, Massachusetts. Learn more at www.zealandpharma.com .